CD8A and neoplasm: However, combination therapy promoted a significant increase in CD8+ TILs during tumor resolution (day 25) (Fig. 3f and Supplementary Fig. 4), with a gradual and significant increase in CD8+ TIL to Treg ratio (Fig. 3g).